Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery

International Journal of Cardiology

Volumn 105, Issue 2, 2005, Pages 209-215

  Rakici, Ozlem ^a   Kiziltepe, Ugursay ^b   Coskun, Bahar ^a   Aslamaci, Sait ^c   Akar, Fatma ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c BASKENT UNIVERSITY   (Turkey)

Author keywords

Endothelial function; Human vessel; Internal mammary artery; Resveratrol; Saphenous vein

Indexed keywords

ACETYLCHOLINE; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; RESVERATROL;

ADULT; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ENDOTHELIUM; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN; SMOOTH MUSCLE RELAXATION; STATISTICAL SIGNIFICANCE;

ACETYLCHOLINE; ANTIOXIDANTS; CORONARY ARTERY BYPASS; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOMETHACIN; MALE; MAMMARY ARTERIES; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; SAPHENOUS VEIN; STILBENES; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 27244432214     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.01.013     Document Type: Article

References (35)

1. C. Napoli, and I.J. Ignarro Nitric oxide and atherosclerosis Nitric Oxide 5 2001 88 97
2. T.F. Luscher, and G. Noll The pathogenesis of cardiovascular disease: role of the endothelium as target and mediator Atherosclerosis 188 1995 S81 S90
3. B.W. Lytle, F.D. Loop, and D.M. Cosgrove Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass graft J Thorac Cardiovasc Surg 89 1985 248 258
4. F.L. Rosenfeldt, H. Guo-Wie, B.F. Buxton, and J.A. Angus Pharmacology of coronary artery bypass grafts Ann Thorac Surg 67 1999 878 888
5. A. Chaikhouini, F.A. Crawford, P.J. Kochel, L.S. Olanoff, and P.V. Halushka Human internal mammary artery produces more prostacyclin than saphenous vein J Thorac Cardiovasc Surg 92 1986 88 91
6. T.F. Luscher, D. Diederich, R. Siebenmann, K. Lehmann, P. Stulz, and L. von Segesser Difference between endothelium-dependent relaxation in arterial and venous coronary bypass grafts N Engl J Med 319 1988 462 467
7. F. Akar, B.S. Uydes, K. Ayrancioglu, A. Yener, S. Aslamaci, and M. Arsan Endothelial function of human gastroepiploic artery in comparison with saphenous vein Cardiovasc Res 28 1994 500 504
8. S. Renaud, and M. de Lorgeril Wine alcohol, platelet and the French paradox for coronary heart disease Lancet 339 1992 1523 1526
9. J.B. German, and R.L. Walzem The health benefits of wine Annu Rev Nutr 20 2000 561 593
10. D. Fitzpatrick, S.L. Hircchfield, and R.G. Coffey Endothelium-dependent vasorelaxing activity of wine and other grape products Am J Physiol 265 1993 H774 H778
11. E. Andriambeloson, A.L. Kleschyov, B. Muller, A. Beretz, J.C. Stoclet, and R. Andriantsitohaina Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenolics in rat aorta Br J Pharmacol 120 1997 1053 1058
12. M. Flesh, A. Schwarz, and M. Böhm Effect of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries Am J Physiol 275 1998 H1183 H1190
13. J.F. Leikert, T.R. Rathel, P. Wohlfart, V. Cheynier, A.M. Vollmar, and V.M. Dirsch Red wine polyphenols enhance endothelial nitric oxide release from endothelial cells Circulation 106 2002 1614 1617
14. H.S. Demrow, and P.R. Slane Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries Circulation 91 1995 1182 1188
15. E.N. Frankel, J. Kanner, J.E. Kinsella, J.B. German, E. Parks, and J.E. Kinsella Inhibition of oxidation of human low-density lipoprotein with red wine Lancet 341 1993 454 457
16. C.K. Chen, and C.R. Pace-Asciak Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta Gen Pharmacol 27 1996 336 363
17. T. Wallerath, G. Deckert, T. Ternes, H. Anderson, H. Li, and K. Wine Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase Circulation 106 2002 1652 1658
18. C.R. Pace-Asciak, S.E. Hahn, E.P. Diamandis, G. Soleas, and D.M. Goldberg The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implication for protection against coronary heart disease Clin Chim Acta 235 1995 207 219
19. S. Rotondo, G. Rajtar, and S. Manarinis Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function Br J Pharmacol 123 1998 1691 1699
20. E.N. Frankel, A.L. Waterhouse, and J.E. Kinsella Inhibition of human DL oxidation by resveratrol Lancet 341 1993 1103 1104
21. U. Jager, and H. Nguyen-Doung Relaxant effect of trans-resveratrol on isolated porcine coronary arteries Arzneim-Forsch 49 1999 207 211
22. E.K. Naderali, S.L. Smith, P.J. Doyle, and G. Williams The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats Clin Sci 100 2001 55 60
23. E.K. Naderali, P.J. Doyle, and G. Williams Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs Clin Sci 98 2000 537 543
24. F. Orallo, E. Alvarez, M. Camina, J.M. Leiro, E. Gomez, and P. Fernandez The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption Mol Pharmacol 61 2002 294 302
25. C.A. Hamilton, M.J. Brosnan, S. Al-Benna, and G. Berg Dominiczak AF NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels Hypertension 40 2002 755 762
26. U. Kiziltepe, N.D. Turan, H. Han, A.T. Ulus, and F. Akar Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury J Vasc Surg 40 2004 138 145
27. A.M. El-Mowafy Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signalling mechanism in support of coronary protection Biochem Biophys Res Commun 291 5 2002 1218 1224
28. M.S. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, and C.W.W. Beecher Cancer chemopreventive activity of resveratrol a natural product derived from grapes Science 275 1997 218 220
29. T.C. Hsieh, G. Juan, Z. Darzynkiewicz, and J.M. Wu Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21WAF1/CIP1 and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2 Cancer Res 59 1999 2596 2601
30. S. Verma, F. Lovren, A.S. Dumont, K.J. Mather, A. Maitland, and T.M. Keiser Tetrahydrobiopterin improves endothelial function in human saphenous veins J Thorac Cardiovasc Surg 120 2000 668 671
31. S. Verma, F. Lovren, A.S. Dumont, K.J. Mather, A. Maitland, and T.M. Keiser Endothelin receptor blockade improves endothelial function in human internal mammary artery Cardiovasc Res 49 2001 146 151
32. L. Ko, A. Maitland, P.M.W. Fedak, A.S. Dumont, M. Badwala, and F. Lovren Endothelin blockade potentiates endothelial protective effects of ACE inhibitors in saphenous veins Ann Thorac Surg 73 2002 1185 1188
33. A. Bertelli, A.A. Bertelli, A. Gozzini, and L. Giovannini Plasma and tissue resveratrol concentrations and pharmacological activity Drugs Exp Clin Res 24 1998 133 138
34. A.A.E. Bertelli, L. Giovannini, R. Stradi, S. Urein, J.P. Tillement, and A. Bertelli Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats Drugs Exp Clin Res 24 1998 51 55
35. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin Biochem 36 2003 79 87